Found 12 results
Author [ Title(Desc)] Type Year
Filters: Author is First, MR  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
J. A. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Salm, K., Fitzsimmons, W. E., First, M. R., Tolzman, D., and Gao, J., A Randomized, Prospective, Multicenter Comparison of Tacrolimus, Mycophenolate Mofetil (MMF) and Steroids vs Cyclosporine Microemulsion, MMF and Steroids vs Tacrolimus, Sirolimus and Steroids in De Novo Cardiac Transplant Recipients - 12 Month Report, in International Society for Heart and Lung Transplantation, Philadelphia, PA, 2005.
J. A. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Salm, K., Fitzsimmons, W. E., First, M. R., Tolzman, D., and Gao, J., A Randomized, Prospective, Multicenter Comparison of Tacrolimus, Mycophenolate Mofetil (MMF) and Steroids vs Cyclosporine Microemulsion, MMF and Steroids vs Tacrolimus, Sirolimus and Steroids in De Novo Cardiac Transplant Recipients - 12 Month Report, in American Transplant Congress, Seattle, WA, 2005.
J. A. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Salm, K., Fitzsimmons, W. E., First, M. R., Tolzman, D., and Gao, J., A randomized, prospective, multicenter comparison of tacrolimus, mycophenolate mofetil (mmf) and steroids vs cyclosporine microemulsion, mmf and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplant recipients 12 month report, 2004.
J. A. Kobashigawa, Miller, L., Russell, S., Ewald, G., Zucker, M., Goldberg, L., Salm, K., Washington, R., Fitzsimmons, W. E., First, M. R., Gao, J., and Inc., F. Healthcare, A randomized, prospective, multicenter comparison of Tacrolimus, Mycophenolate Mofetil (mmf) and steroids vs Cyclosporine Microemulsion, (mmf) and steroids vs Tacrolimus, Sirolimus and steroids in de novo cardiac transplant recipients - 6 month report, 2004.
W. E. Fitzsimmons, First, M. R., Gao, J., and Inc., F. Healthcare, The relationship of Tacrolimus blood levels to efficacy and adverse events in kidney transplant patients treated with mycophenolate mofetil (MMF) or Sirolimus, 2004.